Timing of meal insulin boluses to achieve optimal postprandial glycemic control in patients with type 1 diabetes.
about
The Role of Dietary Protein and Fat in Glycaemic Control in Type 1 Diabetes: Implications for Intensive Diabetes ManagementIncreasing local blood flow by warming the application site: beneficial effects on postprandial glycemic excursionsContinuous glucose monitoring: current use and future directionsMulticenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes.The use of insulin pumps in youth with type 1 diabetes.Premeal injection of rapid-acting insulin reduces postprandial glycemic excursions in type 1 diabetes.Inpatient trial of an artificial pancreas based on multiple model probabilistic predictive control with repeated large unannounced meals.Reduction of postprandial glycemic excursions in patients with type 1 diabetes: a novel human insulin formulation versus a rapid-acting insulin analog and regular human insulin.Clinical performance of a device that applies local heat to the insulin infusion site: a crossover study.Outpatient assessment of determinants of glucose excursions in adolescents with type 1 diabetes: proof of concept.Does eating during television viewing affect mealtimes in young children with type 1 diabetes mellitus?Differences in the management of type 1 diabetes among adults under excellent control compared with those under poor control in the T1D Exchange Clinic RegistryFaster-acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart.Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.A Pooled Analysis of Clinical Pharmacology Trials Investigating the Pharmacokinetic and Pharmacodynamic Characteristics of Fast-Acting Insulin Aspart in Adults with Type 1 Diabetes.Diabetes technology and treatments in the paediatric age group.The role of insulin glulisine to improve glycemic control in children with diabetes mellitus.Ultrafast-acting insulins: state of the artFaster-acting insulin aspart provides faster onset and greater early exposure vs insulin aspart in children and adolescents with type 1 diabetes mellitus.Towards a Physiological Prandial Insulin Profile: Enhancement of Subcutaneously Injected Prandial Insulin Using Local Warming Devices.Pursuit of a perfect insulin.Accurate Carbohydrate Counting Is an Important Determinant of Postprandial Glycemia in Children and Adolescents With Type 1 Diabetes on Insulin Pump Therapy.Challenges and Recent Progress in the Development of a Closed-loop Artificial Pancreas.Boluses in Insulin Therapy.The Need for Faster Insulin.Reasons for missed meal-time insulin boluses from the perspective of adolescents using insulin pumps: 'lost focus'.Optimal prandial timing of bolus insulin in diabetes management: a review.Timing of Meal Insulin and Its Relation to Adherence to Therapy in Type 1 Diabetes.U-100, pH-Neutral formulation of VIAject(®) : faster onset of action than insulin lispro in patients with type 1 diabetes.Therapy of Type 1 Diabetes Mellitus
P2860
Q26800535-43643A5B-B78A-4F75-82EB-A923DFB470F0Q26823106-DBC6D93F-40DF-4336-BC43-0091086714D0Q30354773-4E822262-A869-42E8-8582-69EC48087D00Q30370610-1E48351E-07B7-4675-8B9C-A01841016282Q34113920-5F395CE3-EAA3-40EB-B814-24954BCA2091Q34153420-207ACCA5-5C0C-48F9-9180-25D94D42F116Q34360613-35574D14-EDDC-41D0-B10C-167F61928213Q35337607-660E08E9-9EDC-4C73-89EC-F9598D71FE90Q36051244-1D787656-1AA3-441A-A46A-5504F67B74A6Q36131580-9E06198E-B18D-4131-B36F-5FBA4100E2ADQ36763770-9A20F010-8BE6-49BC-9199-63FC539B49D7Q37278206-87A4C9B7-4A9B-4FD2-9CB0-96008AC0C070Q37320243-343E75D6-FD50-4084-A25E-8D380D29219EQ37595832-27702EE8-520D-4ED6-B20A-F1E1703E2E45Q37742600-F96A2FB9-282B-4F54-8C63-8F1CD8982AC3Q37842725-F1CB0337-56D7-4F29-BF4D-EB207A37E83FQ37857690-58F0BE6B-13A9-43BF-A819-21F68A44AF8FQ38037727-0E91449C-4C8E-4928-BB1E-7327DEBDBB8EQ38381201-E539DC15-6A3C-4AB4-9383-682DD54D2DCAQ38578266-22C0B225-B00C-4554-967F-33ED03E1A13AQ38778988-4DCF8B59-A764-4816-9618-172AC79A541AQ39166574-BCA30347-18A0-4ADA-B632-E03065AF9F8DQ41458753-D416DDE9-96B3-4E80-97FD-BF6A85A3060EQ42293182-7EE7BE13-31D7-4277-B518-9256B9CEB455Q43143808-E9F01ECD-287C-40EF-A687-B405002F3028Q46938067-12F72658-38E0-448C-89AC-5FE42D92FFF8Q47769561-C07352EB-6A35-4E64-BB33-BFA9E53F73D6Q50141722-9E919EC5-8A28-4BF0-B654-AE5E72F35555Q51367050-950E5CAB-8F16-4D09-A944-D360847155E9Q57412611-DB363D8D-6A84-4823-A67F-CF8E46108BFE
P2860
Timing of meal insulin boluses to achieve optimal postprandial glycemic control in patients with type 1 diabetes.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Timing of meal insulin boluses ...... patients with type 1 diabetes.
@en
Timing of meal insulin boluses ...... patients with type 1 diabetes.
@nl
type
label
Timing of meal insulin boluses ...... patients with type 1 diabetes.
@en
Timing of meal insulin boluses ...... patients with type 1 diabetes.
@nl
prefLabel
Timing of meal insulin boluses ...... patients with type 1 diabetes.
@en
Timing of meal insulin boluses ...... patients with type 1 diabetes.
@nl
P2093
P356
P1476
Timing of meal insulin boluses ...... patients with type 1 diabetes.
@en
P2093
Brandon VanderWel
Erin Cobry
H Peter Chase
Kim McFann
Laurel Messer
Lauren Horton
Victoria Gage
P304
P356
10.1089/DIA.2009.0112
P577
2010-03-01T00:00:00Z